Shuttle Pharmaceuticals Holdings, Inc. Cash And Cash Equivalents At Carrying Value

• Shuttle Pharmaceuticals Holdings, Inc. showed a decrease of -82.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Shuttle Pharmaceuticals Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
• XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2023: $7.17 million | Q2 2023: $5.45 million | Q3 2023: $3.89 million | Q1 2024: $1.40 million | Q2 2024: $695.6 thousand | Q3 2024: $156.7 thousand | Q1 2025: $4.51 million | Q2 2025: $4.82 million | Q3 2025: $2.09 million.
• Over the full 5 years of available data (2021 to 2025), Shuttle Pharmaceuticals Holdings, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 33.8%.
• Historical annual values: Fiscal year 2025: $334.0 thousand | Fiscal year 2024: $1.92 million | Fiscal year 2023: $2.58 million | Fiscal year 2022: $8.42 million | Fiscal year 2021: $504.7 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026